生物材料介导的铁化代谢调节用于癌症免疫疗法
Yingqi Liu1, Dan Tao2, Menghuan Li1
1School of Life Sciences, Chongqing University, Chongqing, People's Republic of China.
Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology
|November 4, 2024
概括
铁灭,细胞死亡途径,是癌症治疗的关键. 生物衍生材料可以利用其代谢调节来提高抗瘤免疫力.
科学领域:
- 生物材料科学 生物材料科学
- 癌症生物学 癌症生物学
- 免疫治疗是一种免疫疗法.
背景情况:
- 铁亡是一种由脂质过氧化驱动的细胞死亡途径,对癌症治疗有重大影响.
- 铁亡与瘤代谢和瘤微环境密切相关,影响免疫细胞的通信.
- 了解铁亡的代谢调节对于开发有效的癌症免疫疗法至关重要.
研究的目的:
- 审查瘤新陈代谢,铁亡和免疫调节之间的相互作用.
- 分析基于生物材料的策略,调节瘤代谢以诱导铁灭的最新进展.
- 探索ferroptosis介导免疫疗法的潜力.
主要方法:
- 关于铁亡,瘤代谢和生物材料的综合文献综述.
- 对基于生物衍生材料的平台进行分析,以在现场进行代谢调制.
- 讨论引发铁亡和增强抗瘤免疫力的策略.
主要成果:
- 生物材料平台提供了新的方法来调节瘤代谢以诱导铁亡.
- 通过生物材料向铁亡可以增强抗瘤免疫反应.
- 这些策略对瘤特异性铁死诱导和最大限度地提高免疫刺激效果充满希望.
结论:
- 基于生物材料的代谢调节代表了铁质中介癌症免疫治疗的有希望的途径.
- 需要对调节新陈代谢的生物材料进行进一步的研究,以克服当前的挑战.
- 这种方法可以显著提高瘤免疫疗法在临床环境中的疗效.
更多相关视频
相关概念视频
Necrosis
4.3K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.3K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Tumor Immunotherapy
484
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
484
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Electron Transport Chain: Complex I and II
11.9K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
11.9K


